Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.
Polverelli N, Anghilieri M, Elena C, Intermesoli T, Pungolino E, D'Adda M, Iurlo A, Maffioli M, Lunghi F, Bertolli V, Orofino N, Sissa C, Fiamenghi C, Gardellini A, Ubezio M, Carraro MC, Corradini P, Giglio F, Pasquini MC, Palazzolo R, Calori R, Ercolanoni M, Gambacorti-Passerini C. Polverelli N, et al. Among authors: orofino n. Hematol Oncol. 2024 Sep;42(5):e3311. doi: 10.1002/hon.3311. Hematol Oncol. 2024. PMID: 39305481
Bosutinib Treatment of Chronic Myeloid Leukemia in Lombardy.
Iurlo A, Bucelli C, Intermesoli T, Elena C, D'Adda M, Agostani E, Fiamenghi C, Maffioli M, Orofino N, Lunghi F, Gardellini A, Carraro MC, Inzoli A, Gigli F, Palazzolo R, Bertolli V, Cattaneo D, Pungolino EM, Gambacorti-Passerini C. Iurlo A, et al. Among authors: orofino n. Acta Haematol. 2024 Sep 18:1-5. doi: 10.1159/000540572. Online ahead of print. Acta Haematol. 2024. PMID: 39293408
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Soverini S, Bavaro L, De Benedittis C, Martelli M, Iurlo A, Orofino N, Sica S, Sorà F, Lunghi F, Ciceri F, Galimberti S, Baratè C, Bonifacio M, Scaffidi L, Castagnetti F, Gugliotta G, Albano F, Russo Rossi AV, Stagno F, di Raimondo F, D'Adda M, di Bona E, Abruzzese E, Binotto G, Sancetta R, Salvucci M, Capodanno I, Girasoli M, Coluzzi S, Attolico I, Musolino C, Calistri E, Annunziata M, Bocchia M, Stella S, Serra A, Errichiello S, Saglio G, Pane F, Vigneri P, Mignone F, Laginestra MA, Pileri SA, Percesepe A, Tenti E, Rosti G, Baccarani M, Cavo M, Martinelli G. Soverini S, et al. Among authors: orofino n. Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969. Blood. 2020. PMID: 31877211 Free article.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Crugnola M, Castagnetti F, Breccia M, Ferrero D, Trawinska MM, Abruzzese E, Annunziata M, Stagno F, Tiribelli M, Binotto G, Bonifacio M, Fava C, Iurlo A, Bucelli C, Mansueto G, Gozzini A, Falzetti F, Montefusco E, Crisà E, Gugliotta G, Russo S, Cedrone M, RussoRossi A, Pregno P, Isidori A, Mauro E, Atelda R, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Galimberti S, Orlandi E, Calistri E, Bocchia M, Cavazzini F, Rege Cambrin G, Orofino N, Luciano L, Sgherza N, Rosti G, Latagliata R, Capodanno I. Crugnola M, et al. Among authors: orofino n. Ann Hematol. 2019 Oct;98(10):2329-2338. doi: 10.1007/s00277-019-03767-y. Epub 2019 Aug 7. Ann Hematol. 2019. PMID: 31392461 Clinical Trial.
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
Iurlo A, Elli EM, Palandri F, Cattaneo D, Bossi A, Cortinovis I, Bucelli C, Orofino N, Brioschi F, Auteri G, Bianchi P, Fabris S, Isimbaldi G, Sabattini E, Baldini L, Gianelli U. Iurlo A, et al. Among authors: orofino n. Hematol Oncol. 2019 Oct;37(4):424-433. doi: 10.1002/hon.2658. Epub 2019 Aug 22. Hematol Oncol. 2019. PMID: 31359447
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study).
Elli EM, Iurlo A, Aroldi A, Caramella M, Malato S, Casartelli E, Maffioli M, Gardellini A, Carraro MC, D'Adda M, Polverelli N, Rossi M, Orofino N, Carrer A, Gambacorti-Passerini C, Antolini L, Passamonti F. Elli EM, et al. Among authors: orofino n. Br J Haematol. 2019 Sep;186(5):e123-e126. doi: 10.1111/bjh.15964. Epub 2019 May 20. Br J Haematol. 2019. PMID: 31106402 Free article. No abstract available.
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
Fracchiolla NS, Sciumè M, Orofino N, Guidotti F, Grancini A, Cavalca F, Freyrie A, Goldaniga MC, Consonni D, Mattiello V, Pettine L, Cortelezzi A. Fracchiolla NS, et al. Among authors: orofino n. PLoS One. 2019 May 9;14(5):e0216715. doi: 10.1371/journal.pone.0216715. eCollection 2019. PLoS One. 2019. PMID: 31071175 Free PMC article.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Tiribelli M, Bonifacio M, Binotto G, Iurlo A, Cibien F, Maino E, Guella A, Festini G, Minotto C, De Biasi E, De Marchi F, Scaffidi L, Frison L, Bucelli C, Medeot M, Calistri E, Sancetta R, Stulle M, Orofino N, Krampera M, Gherlinzoni F, Semenzato G, Pizzolo G, Ambrosetti A, Fanin R. Tiribelli M, et al. Among authors: orofino n. Oncotarget. 2018 Feb 12;9(18):14219-14227. doi: 10.18632/oncotarget.24478. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581839 Free PMC article.
33 results